Enzyme hunters at UiO have discovered the function of an enzyme that is important in the spreading of cancer. Cancer researchers now hope to inhibit the enzyme.
Cancer Nov 15, 2012 | 5 / 5 (1) | 0 |
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism Nov 07, 2012 | not rated yet | 0
Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.
Cardiology Nov 06, 2012 | 4 / 5 (2) | 0 |
When a person has a heart attack, portions of the heart muscle die in the next several days or even weeks if deprived of oxygen for long enough. The recovering heart slowly remodels itself, even fostering the growth of new ...
Cardiology Nov 06, 2012 | not rated yet | 0
Animal-model research examines molecular mechanisms for blood-pressure lowering effect of ancient Chinese therapy
(Medical Xpress)—An increase in antioxidant enzymes triggered by acupuncture appeared to play a role in reducing high blood pressure in hypertensive rats treated with the ancient Chinese therapy, a study ...
Health Nov 02, 2012 | not rated yet | 0 |
A team of researchers under the direction of Dr. Jeffrey Teckman in the Department of Pediatrics at St. Louis University, have demonstrated that oxidative stress occurs in a genetic model of alpha-1-antitrypsin deficiency. ...
Medical research Oct 30, 2012 | not rated yet | 0
In a new paper released today in Nature, BioFrontiers Institute scientists at the University of Colorado Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development that is sitting at the ...
Cancer Oct 24, 2012 | 4.8 / 5 (4) | 0 |
Breast cancer cells puncture holes into neighbouring tissues and crawl though the spaces they create to spread around the body, according to research published in the Journal of Cell Biology.
Cancer Oct 23, 2012 | not rated yet | 0 |
The Molecular and Industrial Biotechnology Group of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) has improved the antimicrobial properties of medical textiles using an enzymatic pre-treatment combined ...
Other Oct 16, 2012 | not rated yet | 0
Adding a third anti-cancer agent to a current drug cocktail appears to have contributed to dramatic improvement in three infants with the most severe form of Pompe disease—a rare, often-fatal genetic disorder ...
Genetics Oct 11, 2012 | 3.5 / 5 (2) | 0
An international research team led by the Spanish National Research Council (CSIC) and researchers from Kiel University revealed the atomic‐level structure of the human peptidase enzyme meprin β (beta). ...
Alzheimer's disease & dementia Oct 04, 2012 | not rated yet | 0
Researchers from IMIM, Hospital del Mar Medical Research Institute, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKα) to activate some of the genes taking part in the tumor progressions ...
Cancer Oct 04, 2012 | not rated yet | 0
(Medical Xpress)—Eating an apple a day might in fact help keep the cardiologist away, new research suggests.
Health Oct 02, 2012 | 5 / 5 (9) | 3 |
(HealthDay)—Stivarga (regorafenib) has been approved by the U.S. Food and Drug Administration to treat colorectal cancer that has spread despite prior treatment.
Medications Sep 27, 2012 | not rated yet | 0
As part of their ongoing research investigating the biology of aging, the greatest risk factor for type 2 diabetes and other serious diseases, scientists at Joslin Diabetes Center have identified a new factor—microRNA ...
Medical research Sep 26, 2012 | 5 / 5 (5) | 1 |